AUS
NZ
UK
CA
USA
IND
Highlights
- In FY24, C79’s EBITDA surged by 156% YoY to AUD 8.98 million; however, the company reported a net loss of AUD 0.7 million
- C79 is expanding internationally, though indirect costs are becoming progressively incremental.
- The company forecasts FY25 revenue of AUD 60–70 million and EBITDA in the range of AUD 9–19 million.
Chrysos Corporation Limited (ASX:C79) is an Australia-based company that provides assay technologies and services. The company’s services include PhotonAssay, a cutting-edge technology used for analysis of copper, silver, gold and multiple other elements.
The continued deployment of PhotonAssay units resulted in more than 69% YoY rise in the total revenue to AUD 45.39 million. During the reported period, EBITDA increased by over 156% YoY to AUD 8.98 million and net loss reached AUD 0.7 million, compared to profit of AUD 0.44 million in FY23.
The jump in EBITDA in FY24 demonstrates C79’s increasing economies of scale. The company focuses on expanding its international footprint. With this, surge in indirect costs is becoming progressively incremental.
Company outlook
In FY25, the company expects to deliver revenue of around AUD 60 – 70 million, if the revenue per unit remains consistent with FY24. EBITDA is expected to remain in the range of AUD 9 – 19 million.
Share performance of C79
C79 shares closed 2.13% lower at AUD 5.05 apiece on 21 October 2024. Over the past year, C79’s share piece has declined by almost 20.85%, while in the last three months, it has decreased by around 9.17%.
52-week high of C79 is around AUD 8.72, recorded on 10 January 2024, while 52-low is AUD 4.40 apiece, recorded on 25 July 2024.
C79 Daily Technical Chart, Source: EODHD/Others
Note 1: Past performance is neither an Indicator nor a guarantee of future performance.
Note 2: The reference date for all price data, and currency, is 21 October 2024. The reference data in this report has been partly sourced from EODHD/Others.
Disclaimer
This article has been prepared by Kalkine Media, echoed on the website kalkinemedia.com/au and associated pages, based on the information obtained and collated from the subscription reports prepared by Kalkine Pty. Ltd. [ABN 34 154 808 312; AFSL no. 425376] on Kalkine.com.au (and associated pages). The principal purpose of the content is to provide factual information only for educational purposes. None of the content in this article, including any news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video is or is intended to be, advisory in nature. The content does not contain or imply any recommendation or opinion intended to influence your financial decisions, including but not limited to, in respect of any particular security, transaction, or investment strategy, and must not be relied upon by you as such. The content is provided without any express or implied warranties of any kind. Kalkine Media, and its related bodies corporate, agents, and employees (Kalkine Group) cannot and do not warrant the accuracy, completeness, timeliness, merchantability, or fitness for a particular purpose of the content or the website, and to the extent permitted by law, Kalkine Group hereby disclaims any and all such express or implied warranties. Kalkine Group shall NOT be held liable for any investment or trading losses you may incur by using the information shared on our website.
